Kyowa Hakko Bio Co., Ltd., a prominent player in the biotechnology industry, is headquartered in Japan. Established in 1949, the company has made significant strides in the development of amino acids, nucleic acids, and fermentation products, catering to diverse sectors such as pharmaceuticals,
How does KYOWA HAKKO BIO CO.,LTD.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
KYOWA HAKKO BIO CO.,LTD.'s score of 76 is higher than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, KYOWA HAKKO BIO CO., LTD. reported total carbon emissions of approximately 305,000 kg CO2e. This figure includes 33,000 kg CO2e from Scope 1 emissions, 96,000 kg CO2e from Scope 2 emissions, and 176,000 kg CO2e from Scope 3 emissions. This represents a decrease from 2022, when total emissions were about 363,000 kg CO2e, with Scope 1 at 40,000 kg CO2e, Scope 2 at 131,000 kg CO2e, and Scope 3 at 193,000 kg CO2e. Over the past few years, the company has shown a trend of reducing its overall emissions, with a notable decline from 408,000 kg CO2e in 2020 and 392,000 kg CO2e in 2021. Despite these reductions, KYOWA HAKKO BIO has not publicly committed to specific reduction targets or initiatives under the Science Based Targets initiative (SBTi) or other climate pledges. The company continues to disclose emissions across all three scopes, indicating a commitment to transparency in its climate impact. As it moves forward, further initiatives and targets may be necessary to enhance its sustainability efforts and align with global climate goals.
Access structured emissions data, company-specific emission factors, and source documents
2001 | 2002 | 2005 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|
Scope 1 | 708,202,000 | 000,000,000 | 000,000,000 | 00,000 | 00,000 | 00,000 | 00,000 | 00,000 |
Scope 2 | 1,176,000 | 0,000,000 | - | 000,000 | 000,000 | 000,000 | 000,000 | 00,000 |
Scope 3 | 650,000 | 000,000 | - | 000,000 | 000,000 | 000,000 | 000,000 | 000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
KYOWA HAKKO BIO CO.,LTD. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.